Elucidating Key Components and Mechanisms Underlying the Synergistic Anti-Type 2 Diabetes Effect of Morus alba L. and Siraitia grosvenorii Combination: An Integrated In Vitro Enzymology, Untargeted Metabolomics, and Network Pharmacology Approach
Open Access
- 29 August 2025
- journal article
- research article
- Published by MDPI AG in Antioxidants
- Vol. 14 (9) , 1065
Abstract
Although mulberry leaf (Morus alba L., ML) and Siraitia grosvenorii (SG) individually demonstrate anti-diabetic properties, their combined efficacy against type 2 diabetes mellitus (T2DM) remains unexplored. This study systematically explored the multi-target mechanisms and synergistic potential of the MLSG combination (MLSG) for T2DM intervention. We evaluated the in vitro inhibitory activities of MLSG, ML, and SG on α-amylase and α-glucosidase, alongside antioxidant capacity assessments through DPPH/ABTS radical scavenging, reducing power, and FRAP assays. Bioactive metabolites were identified using non-targeted metabolomics, while core targets and pathways were predicted using network pharmacology and validated through molecular docking. The results reveal MLSG’s significantly enhanced inhibition of α-amylase (IC50 = 14.06 mg/mL) and α-glucosidase (IC50 = 0.02 mg/mL) compared to individual extracts, exhibiting 1.3–15.5-fold higher potency with synergistic effects (combination index < 1). MLSG also showed improved antioxidant capacity, outperforming SG in DPPH/ABTS+ scavenging and reducing power (p < 0.05), and surpassing ML in ABTS+ scavenging, reducing power, and FRAP values (p < 0.05). Metabolomics identified 26 MLSG-derived metabolites with anti-T2DM potential, and network analysis pinpointed 26 active components primarily targeting STAT3, AKT1, PIK3CA, EGFR, and MAPK1 to regulate T2DM pathways. Molecular docking confirmed strong binding affinities between these components and core targets. Collectively, MLSG exerts potent synergistic anti-T2DM effects through dual-enzyme inhibition, elevated antioxidant activity, and multi-target pathway regulation, providing a solid foundation for developing MLSG as functional food ingredients.Keywords
This publication has 50 references indexed in Scilit:
- Clinical research progress on β-cell dysfunction in T2DM development in the Chinese populationReviews in Endocrine and Metabolic Disorders, 2024
- The bioavailability, absorption, metabolism, and regulation of glucolipid metabolism disorders by quercetin and its important glycosides: A reviewFood Chemistry, 2024
- Quercetin analogs as α-glucosidase inhibitors with antidiabetic activityFood Bioscience, 2024
- Nuciferine relieves type 2 diabetes mellitus via enhancing GLUT4 expression and translocationFood Science and Human Wellness, 2023
- Mechanistic study on the inhibition of α‐amylase and α‐glucosidase using the extract of ultrasound‐treated coffee leavesJournal of the Science of Food and Agriculture, 2023
- Effects of gefitinib treatment on cellular uptake of extracellular vesicles in EGFR-mutant non-small cell lung cancer cellsInternational Journal of Pharmaceutics, 2019
- A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In VivoCancer Cell, 2019
- In vitro and in vivo evidence that quercetin protects against diabetes and its complications: A systematic review of the literatureBiomedicine & Pharmacotherapy, 2019
- Umbelliferone Improves an Impaired Glucose and Lipid Metabolism in High-Fat Diet/Streptozotocin-Induced Type 2 Diabetic RatsPhytotherapy Research, 2015
- Genistein and daidzein prevent diabetes onset by elevating insulin level and altering hepatic gluconeogenic and lipogenic enzyme activities in non‐obese diabetic (NOD) miceDiabetes/Metabolism Research and Reviews, 2007